KP Tissue Inc. (TSE:KPT)
TSX:KPT
Want to see TSE:KPT full AI Analyst Report?
Total Valuation
KP Tissue has a market cap or net worth of C$131.11M. The enterprise value is C$122.17M.
Market CapC$131.11M
Enterprise ValueC$122.17M
Share Statistics
KP Tissue has 10,027,711 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,027,711
Owned by Insiders0.43%
Owned by Institutions2.41%
Financial Efficiency
KP Tissue’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee901.11
Employee Count2,700
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of KP Tissue is 33.6. KP Tissue’s PEG ratio is -0.23.
PE Ratio33.6
PS Ratio0.00
PB Ratio1.18
Price to Fair Value1.18
Price to FCF11.77
Price to Operating Cash Flow75.41
PEG Ratio-0.23
Income Statement
In the last 12 months, KP Tissue had revenue of 0.00 and earned 2.43M in profits. Earnings per share was 0.24.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income2.49M
Net Income2.43M
EBITDA264.78M
Earnings Per Share (EPS)0.24
Cash Flow
In the last 12 months, operating cash flow was 3.48M and capital expenditures 0.00, giving a free cash flow of 3.48M billion.
Operating Cash Flow3.48M
Free Cash Flow3.48M
Free Cash Flow per Share0.35
Dividends & Yields
KP Tissue pays an annual dividend of C$0.21, resulting in a dividend yield of 7.04%
Dividend Per ShareC$0.21
Dividend Yield7.04%
Payout Ratio-1531.91%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.31
52-Week Price Change52.09%
50-Day Moving Average11.68
200-Day Moving Average10.28
Relative Strength Index (RSI)76.21
Average Volume (3m)17.75K
Important Dates
KP Tissue upcoming earnings date is Aug 6, 2026, Before Open (Confirmed).
Last Earnings DateMay 14, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
KP Tissue as a current ratio of 1.00, with Debt / Equity ratio of 0.00%
Current Ratio1.00
Quick Ratio1.00
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, KP Tissue has paid 56.00K in taxes.
Income Tax56.00K
Effective Tax Rate0.02
Enterprise Valuation
KP Tissue EV to EBITDA ratio is 0.31, with an EV/FCF ratio of 11.77.
EV to Sales0.00
EV to EBITDA0.31
EV to Free Cash Flow11.77
EV to Operating Cash Flow11.77
Balance Sheet
KP Tissue has C$0.00 in cash and marketable securities with C$0.00 in debt, giving a net cash position of C$0.00 billion.
Cash & Marketable SecuritiesC$0.00
Total DebtC$0.00
Net CashC$0.00
Net Cash Per ShareC$0.00
Tangible Book Value Per ShareC$6.97
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for KP Tissue is C$12.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetC$12.00
Price Target Upside6.29% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast192.18%